期刊文献+

抗病毒治疗对抗-HIV阳性美沙酮维持治疗者吸毒和高危性行为的影响 被引量:9

Impacts of antiretroviral treatment on drug use and high risk sexual behaviors among HIV-positive MMT clients
原文传递
导出
摘要 目的了解抗病毒治疗(ART)对美沙酮维持治疗(MMT)门诊抗-HIV阳性吸毒人员高危性行为和吸毒行为的影响。方法采用横断面调查方法,于2014年6—8月对云南省红河州和德宏州5个县(市)的MMT门诊的HIV感染者进行问卷调查,包括参加ART及未参加ART者,收集其人口学特征、参加ART情况、参加MMT情况、艾滋病性病相关行为学特征等内容。对过去3个月与固定性伴发生无保护性行为(UPS)和偷吸毒品的相关因素进行logistic回归分析。结果纳入分析的328例调查对象中,参加ART组202例,未参加ART组126例。调查对象在过去3个月与固定性伴UPS发生率为40.1%(61/152),过去3个月偷吸毒品行为发生率为57.6%(189/328)。多因素分析显示:年龄〈35岁(OR=3.57,95%C/:1.23~10.37)、有生育愿望(OR=4.47,95%Chl.49~13.41)、固定性伴为HIV感染者(OR=4.62,95%CI:1.80~11.86)、参加MMT〈5年(OR=2.92,95%CI:14~7.53)是过去3个月发生UPS的危险因素,认同不管病毒载量高低都需要使用安全套(OR=0.14,95%CI:0.04.0.51)是保护因素。汉族(OR=0.46,95%CI:0.24~0.89)、自我感觉健康状况好(OR=0.39,95%CI:0.18~0.851、参加ART(OR=0.32,95%CI:0.17~0.60)是过去3个月偷吸毒品的保护因素;过去3个月与吸毒的朋友打过交道(OR=4.41,95%CI:2.31-8.29)、在门诊有过漏服药经历(OR=3.47,95%CI:1.92—6.29)、认为当前服药剂量需适当增加(0R=13.92,95%CI:3.24—59.93)是偷吸毒品的危险因素。结论ART不会引起MMT门诊HIV感染者UPS和偷吸毒品行为增加,应鼓励其参加ART,同时给予配套的宣传教育,预防交叉感染和耐药菌株的出现。 Objective To explore the impacts of antiretroviral treatment on drug use and high risk sexual behaviors among HIV-positive MMT clients. Methods A cross-sectional study was conducted in patients undergoing ART(ART-experienced) and patients not undergoing ART(ART-naive) attending MMT in 5 clinics in Yunnan Honghe and Dehong prefectures in 2014. A questionnaire was designed to collect socio-demographic characteristics, ART and MMT information and sexual and drug use behaviors within 3 months before the investigation was conducted. Logistic regression analysis was conducted to identify the predictors for drug use and risky sexual behaviors. Results A total of 328 cases were included in the analysis, among which 202 were ART-experienced and 126 were ART-naive. Among 152 respondents who were sexually active, 61 (40.1%) reported having unprotected sex(UPS) with their regular partners in the prior 3 months. A total of 57.6%(189/328) of the respondents used drugs in the prior 3 months. Multiple logistic regression analysis revealed that younger than 35 years old(OR=3.57, 95%CI: 1.23-10.37), fertility desire (OR=4.47, 95%CI:1.49-13.41), partner being HIV-positive(OR=4.62, 95%CI:1.80-11.86), length of MMT attendance less than 5 years(OR=2.92,95%CI:1.14-7.53), agreed that it was necessary to use condom no matter the viral load is high or low(OR=0.14, 95%CI:0.04-0.51) were protective factors of UPS in the prior 3 months. Multiple logistic regression analysis revealed that being Han (OR=0.46, 95%CI:0.24-0.89), feeling having good health status (OR=0.39, 95% CI: 0.18-0.85), being enrolled in ART(OR=0.32, 95%CI:0.17- 0.60) were protective factors for drug use in the prior three months, having contact with drug using friends (OR=4.41, 95% CI:2.31- 8.29), having experience of missing an MMT dose(OR=3.47, 95% CI:1.92- 6.29), and not satisfied with current MMT dose(OR=13.92,95%CI:3.24-59.93) were risk factors for drug use during the prior three months. Conclusion ART was not associated with risky sexual behavior and drug use in the prior 3 months in this population. Future interventions should promote ART among this population, and provide education at the same time to prevent the emergence of cross infections and drug-resistant strains.
出处 《中华预防医学杂志》 CAS CSCD 北大核心 2015年第6期506-512,共7页 Chinese Journal of Preventive Medicine
基金 国家“十二五”科技重大专项(2012ZX10001007-002) 中国艾滋病/结核病多学科研究培训项目(4U2RTW006918-10) 志谢 感谢云南省药物依赖防治研究所、德宏州CDC及各MMT门诊现场工作人员的大力支持,感谢Willa Dong对英文摘要的修改,感谢于石成老师提供的数据分析指导意见
关键词 HIV 危险性行为 美沙酮维持治疗 抗病毒治疗 横断面研究 HIV Unsafe sex Methadone maintenance treatment Antiretroviral treatment Cross-sectional studies
  • 相关文献

参考文献18

  • 1Wu Z, Sullivan SG, Wang Y, et al. Evolution of China's response to HIV/AIDS[J]. Lancet, 2007,369(9562): 679-690.
  • 2曹晓斌,吴尊友,庞琳,柔克明,王常合,罗巍,殷文渊,米国栋,李建华.中国首批8个社区美沙酮维持治疗门诊5年治疗效果分析[J].中华流行病学杂志,2012,33(9):879-882. 被引量:23
  • 3刘恩武,王书江,刘燕,刘伟,陈志胜,李秀英,阿丽娅,吴尊友.伊犁哈萨克自治州接受美沙酮维持治疗的HIV感染者死亡情况[J].中华预防医学杂志,2011,45(11):979-984. 被引量:3
  • 4Zhao Y, Shi CX, McGoogan JM, et al. Methadone maintenance treatment and mortality in HIV-positive people who inject opioids in China[J]. Bull World Health Organ, 2013, 91(2):93-101.
  • 5Dukers NH, Goudsmit J, de Wit JB, et al. Sexual risk behaviour relates to the virological and immunological improvements during highly active antiretroviral therapy in HIV-1 infection[J]. AIDS,2001, 15(3): 369-378.
  • 6Chen SY, Gibson S, Katz MH, et al. Continuing increases in sexual risk behaviour and sexually transmitted diseases among MSM[J]. Am ] Public Health,2002,92(9): 1387-1388.
  • 7Ostrow DE, Fox KJ, Chmiel JS, et al. Attitudes towards highly active antiretroviral therapy are associated with sexual risk taking among HIV-infected and uninfected homosexual men[J]. AIDS,2002,16(5): 775-780.
  • 8Mawji E, McKinnon L, Wachihi C, et al. Does antiretroviral therapy initiation increase sexual risk taking in Kenyan female sex workers? A retrospective case-control study[J]. BMJ Open, 2012, 2(2): e000565.
  • 9McClelland RS, Graham SM, Richardson BA, et al. Treatment with antiretroviral therapy is not associated withincreased sexual risk behavior in Kenyan female sex workers [J]. AIDS, 2010,24(6): 891-897.
  • 10Wilson TE, Gore ME, Greenhlatt R, et al. Changes in sexual behavior among HIV-infected women alter initiation of HAART[J]. Am J Public Health Jul,2004, 94(7): 1141-1146.

二级参考文献28

  • 1R Development Core Team. R: a language and environment for statistical computing, reference index version 2. 13.0 [ CP/DK]. Vienna: R Foundation for Statistical Computing, c2011.
  • 2Hooshyar D, Hanson DL, Wolfe M, et al. Trends in perimortal conditions and mortality rates among HIV-infected patients. AIDS, 2007,21:2093-2100.
  • 3Lohse N, Hansen AB, Pedersen G, et al. Survival of persons with and without HW infection in Denmark, 1995 - 2005. Ann Intern Med,2007,146:87-95.
  • 4Blaney T, Craig RJ. Methadone maintenance. Does dose determine differences in outcome? J Subst Abuse Treat, 1999,16:221-228.
  • 5Brady TM, Salvucci S, Sverdlov LS, et al. Methadone dosage and retention: an examination of the 60 mg/day threshold. J Addict Dis, 2005,24 : 23 -47.
  • 6Liu E, Liang T, Shen L, et al. Correlates of methadone client retention: a prospective cohort study in Guizhou province, China. Int J Drug Policy,2009,20:304-308.
  • 7Nosyk B, Marsh DC, Sun H, et al. Trends in methadone maintenance treatment participation, retention, and compliance to dosing guidelines in British Columbia, Canada: 1996 - 2006. J Subst Abuse Treat ,2010,39:22-31.
  • 8Serpelloni G, Carrieri MP, Rezza G, et al. Methadone treatment as a determinant of HIV risk reduction among injecting drug users : a nested case-control study. AIDS Care, 1994,6:215-220.
  • 9Gelman A, Hill J. Data Analysis using regression and multilevel/ hierarchical models. Cambridge: Cambridge University Press, 2007.
  • 10Darke S, Zador D. Fatal heroin ' overdose' : a review. Addiction, 1996,91 : 1765-1772.

共引文献23

同被引文献101

  • 1谢久明,封蕴,李瞡.毒品滥用者92例心理及社会因素调查[J].中国临床康复,2005,9(20):228-228. 被引量:7
  • 2孙慧敏.农村HIV感染者和AIDS患者应对方式、社会支持及心理健康状况调查分析[J].护理学杂志(综合版),2006,21(12):11-13. 被引量:9
  • 3刘建波,地力夏提.亚合甫,李凡,张峰,莫兰蓉,焦立东,艾尼瓦尔,王金梅.海洛因成瘾者美沙酮维持治疗效果评价[J].中国药物滥用防治杂志,2007,13(1):10-13. 被引量:14
  • 4张福杰.国家免费艾滋病抗病毒药物治疗手册[M].3版.北京:人民卫生出版社,2013:21-22.
  • 5UNAIDS.Global report UNAIDS report on the global AIDS epidemic[EB/OL].[2015-O6-O1].http://www.unaids. org/globalreport/documents/20101123_GlobalReport full en. pdf.
  • 6UNAIDS.Global report UNAIDS report on the global AIDS epidemic[EB/OL].[2015-06-01].http://issuu.com/unaids/docs/ unaids_global_report_2013_en.
  • 7Zhou W,Zhao M,Wang X,et al.Treatment adherence and health outcomes in MSM with HIV/AIDS:patients enrolled in "One-Stop" and standard care clinics in Wuhan China[J].PLoS One,2014,9(12):e 113736.
  • 8Hightow-Weidman LB,Smith JC,Valera E,et al.Keeping them in"STYLE":finding,linking,and retaining young HIV-positive black and Latino men who have sex with men in eare[J].AIDS Patient Care STDS,2011,25(1):37-45.
  • 9Singh S,Bradley H,Hu X,et al.Men living with diagnosed HIV who have sex with men: progress along the continuum of HIV care--United States,2010[J].MMWR Morb Mortal Wkly Rep, 2014,63(38):829-833.
  • 10World Health Organization.Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection[EB/OL].[2015-06-01 ].http://www.chinaaids.cn/jszn/ 201307/P020130718370486650488.pdf.

引证文献9

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部